Streetbeat News

Analyst Ratings

RIVN

Rivian Automotive's stock is trading higher after Baird designated the stock as a bullish 'Fresh Pick'.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:16 pm

AMAT

A significant number of investors have taken a bearish stance on Applied Materials (NASDAQ:AMAT), with 70% of detected trades being bearish. The whales have been targeting a price range from $100.0 to $140.0 for AMAT over the last 3 months. The current price of AMAT is down -1.28% at $134.84. Wolfe Research and Mizuho have downgraded their actions to Outperform and Buy with price targets of $185 and $158 respectively.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 4:15 pm

LLY

A whale investor has taken a bullish stance on Eli Lilly (NYSE:LLY), with 53% of investors opening trades with bullish expectations and 46% with bearish. The whale has been targeting a price range from $320.0 to $630.0 for Eli Lilly over the last 3 months. The current price of LLY is down -0.42% at $549.96. Cantor Fitzgerald downgraded its action to Overweight with a price target of $630, Argus Research maintained their Buy rating with a price target of $620, and Morgan Stanley maintained their Overweight rating with a price target of $640.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 4:15 pm

KFY

Truist Securities analyst Tobey Sommer has reiterated a 'Buy' rating on Korn Ferry (NYSE:KFY) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:15 pm

AMC

Citigroup analyst Jason Bazinet has maintained a 'Sell' rating on AMC Enter Hldgs (NYSE:AMC) and lowered the price target from $15.5 to $4.75.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:14 pm

OMCL

Wells Fargo analyst Stan Berenshteyn has maintained an Underweight rating on Omnicell (NASDAQ:OMCL) and lowered the price target from $56 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:13 pm

GMAB

Truist Securities analyst Asthika Goonewardene has reiterated a 'Buy' rating on Genmab (NASDAQ:GMAB) and maintained a price target of $54.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:12 pm

UAL

Bernstein analyst David Vernon maintains an Outperform rating on United Airlines Holdings (NASDAQ:UAL) but lowers the price target from $79 to $61.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:09 pm

ROIV

Truist Securities analyst Robyn Karnauskas has reiterated a 'Buy' rating on Roivant Sciences (NASDAQ:ROIV) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:09 pm

OI

Truist Securities analyst Michael Roxland has reiterated a 'Buy' rating on O-I Glass (NYSE:OI) and maintained a price target of $31.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:08 pm